111 related articles for article (PubMed ID: 18038514)
21. Evaluating a national dissemination approach: The National Cancer Institute's clinical trials education program.
Solomon FM; Thakkar S; Zambon A; Eckstein DS; Michaels M; Johnson L; Squiers L
J Cancer Educ; 2009; 24(1):49-57. PubMed ID: 19259866
[TBL] [Abstract][Full Text] [Related]
22. Nurses' use and perceptions of usefulness of National Cancer Institute's tobacco-related Cancer Information Service (CIS) resources.
Hyun S; Currie LM; Hodorowski JK; Joyce MP; Lee NJ; Velez O; Bakken S
AMIA Annu Symp Proc; 2008 Nov; ():985. PubMed ID: 18999044
[TBL] [Abstract][Full Text] [Related]
23. The NCI's Cancer Information Service Staff Training Program: a foundation for excellence.
Perocchia RS; Galassi A; Jacobs R; Krauss N; LeMaitre MK; Rutledge S
J Cancer Educ; 2007; 22(1 Suppl):S8-17. PubMed ID: 17572005
[TBL] [Abstract][Full Text] [Related]
24. The National Cancer Institute's cancer information service: a new generation of service and research to the nation.
Bright MA
J Health Commun; 2005; 10 Suppl 1():7-13. PubMed ID: 16377597
[TBL] [Abstract][Full Text] [Related]
25. Cancer-related information sought by the general public: evidence from the National Cancer Institute's Cancer Information Service, 2002-2003.
Finney Rutten LJ; Squiers L; Hesse B
J Cancer Educ; 2007; 22(2):91-8. PubMed ID: 17605622
[TBL] [Abstract][Full Text] [Related]
26. Updates to the National Cancer Institute's PDQ Information from Recently Published Oncology Research.
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954290
[No Abstract] [Full Text] [Related]
27. The NCI's Cancer Information Service: meeting the public's cancer information needs via the internet.
La Porta M; Hagood H; Patt J; Hodorowski JK; Treiman K
J Cancer Educ; 2007; 22(1 Suppl):S26-34. PubMed ID: 17571998
[TBL] [Abstract][Full Text] [Related]
28. National Cancer Institute's support of research to further integrative oncology practice.
White JD
J Natl Cancer Inst Monogr; 2014 Nov; 2014(50):286-7. PubMed ID: 25749590
[No Abstract] [Full Text] [Related]
29. A survey of patient advocates within the National Cancer Institute's Prostate Cancer SPORE Program: who are they? what motivates them? what might they tell us?
Kovtun IV; Engh J; Jatoi A
J Cancer Educ; 2008; 23(4):222-5. PubMed ID: 19058069
[TBL] [Abstract][Full Text] [Related]
30. An Overview of the National Cancer Institute's Initiatives to Accelerate Rural Cancer Control Research.
Kennedy AE; Vanderpool RC; Croyle RT; Srinivasan S
Cancer Epidemiol Biomarkers Prev; 2018 Nov; 27(11):1240-1244. PubMed ID: 30385495
[No Abstract] [Full Text] [Related]
31. Application of nanotechnology in cancer research: review of progress in the National Cancer Institute's Alliance for Nanotechnology.
Ehdaie B
Int J Biol Sci; 2007 Jan; 3(2):108-10. PubMed ID: 17304339
[No Abstract] [Full Text] [Related]
32. National Cancer Institute's New Tool Puts Cancer Risk in Context.
McNeil C
J Natl Cancer Inst; 2015 Dec; 107(12):djv398. PubMed ID: 26657102
[No Abstract] [Full Text] [Related]
33. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service.
Miller SM; Fleisher L; Roussi P; Buzaglo JS; Schnoll R; Slater E; Raysor S; Popa-Mabe M
J Health Commun; 2005; 10 Suppl 1():119-36. PubMed ID: 16377604
[TBL] [Abstract][Full Text] [Related]
34. Translational research in the National Cancer Institute's cooperative groups.
Symmans WF
Clin Adv Hematol Oncol; 2014 Nov; 12(11):785-7. PubMed ID: 25674720
[No Abstract] [Full Text] [Related]
35. The National Cancer Institute's Clinical Trials Innovation Unit.
Morris MJ; Prindiville S
Clin Adv Hematol Oncol; 2023 Dec; 21(12):663-665. PubMed ID: 38039060
[No Abstract] [Full Text] [Related]
36. Reaffirming our values: the Journal of the National Cancer Institute's commitment to excellence and society.
Franco EL
J Natl Cancer Inst; 2024 Jan; 116(1):1-3. PubMed ID: 38197559
[No Abstract] [Full Text] [Related]
37. Open access takes root at National Cancer Institute.
Kaiser J
Science; 2019 Aug; 365(6454):629. PubMed ID: 31416942
[No Abstract] [Full Text] [Related]
38. The potential to backfill in phase I trials: the National Cancer Institute's Cancer Therapy Evaluation Program experience.
Foster JC; Korn EL; Freidlin B; Moscow JA
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 38001028
[No Abstract] [Full Text] [Related]
39. The National Cancer Institute's Efforts in Promoting Research in the Tumor Microenvironment.
Kuhn NZ; Woodhouse EC; Mohla S
Cancer J; 2015; 21(4):263-6. PubMed ID: 26222077
[TBL] [Abstract][Full Text] [Related]
40. The National Cancer Institute's Experimental Therapeutics Clinical Trials Network.
Ivy SP
Clin Adv Hematol Oncol; 2015 Mar; 13(3):144-6. PubMed ID: 26352418
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
